Report Detail

Other Global Oncology Blood Testing Market Size, Status and Forecast 2020-2026

  • RnM3911414
  • |
  • 06 March, 2020
  • |
  • Global
  • |
  • 125 Pages
  • |
  • HJResearch
  • |
  • Other

Oncology blood testing is a revolutionary diagnostic technique to detect cancer in early stages. For early detection of cancer, liquid biopsies have become a popular diagnostic tool.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Blood Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Blood Testing market in terms of revenue.
Players, stakeholders, and other participants in the global Oncology Blood Testing market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Oncology Blood Testing market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Oncology Blood Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Blood Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Blood Testing market.
The following players are covered in this report:
Guardant Health
Trovagene
Genomic Health
Roche
Bio-Techne
Pathway Genomics
...
Oncology Blood Testing Breakdown Data by Type
Blood Protein Testing
Tumor Marker Testing
Others
Oncology Blood Testing Breakdown Data by Application
Hospitals
Clinics
Ambulatory Surgical Centers


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Oncology Blood Testing Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Oncology Blood Testing Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Blood Protein Testing
      • 1.4.3 Tumor Marker Testing
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Oncology Blood Testing Market Share by Application: 2020 VS 2026
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Ambulatory Surgical Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Oncology Blood Testing Market Perspective (2015-2026)
    • 2.2 Oncology Blood Testing Growth Trends by Regions
      • 2.2.1 Oncology Blood Testing Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Oncology Blood Testing Historic Market Share by Regions (2015-2020)
      • 2.2.3 Oncology Blood Testing Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Oncology Blood Testing Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Oncology Blood Testing Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Oncology Blood Testing Players by Market Size
      • 3.1.1 Global Top Oncology Blood Testing Players by Revenue (2015-2020)
      • 3.1.2 Global Oncology Blood Testing Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Oncology Blood Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Oncology Blood Testing Market Concentration Ratio
      • 3.2.1 Global Oncology Blood Testing Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Oncology Blood Testing Revenue in 2019
    • 3.3 Oncology Blood Testing Key Players Head office and Area Served
    • 3.4 Key Players Oncology Blood Testing Product Solution and Service
    • 3.5 Date of Enter into Oncology Blood Testing Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Oncology Blood Testing Historic Market Size by Type (2015-2020)
    • 4.2 Global Oncology Blood Testing Forecasted Market Size by Type (2021-2026)

    5 Oncology Blood Testing Breakdown Data by Application (2015-2026)

    • 5.1 Global Oncology Blood Testing Market Size by Application (2015-2020)
    • 5.2 Global Oncology Blood Testing Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Oncology Blood Testing Market Size (2015-2020)
    • 6.2 Oncology Blood Testing Key Players in North America (2019-2020)
    • 6.3 North America Oncology Blood Testing Market Size by Type (2015-2020)
    • 6.4 North America Oncology Blood Testing Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Oncology Blood Testing Market Size (2015-2020)
    • 7.2 Oncology Blood Testing Key Players in Europe (2019-2020)
    • 7.3 Europe Oncology Blood Testing Market Size by Type (2015-2020)
    • 7.4 Europe Oncology Blood Testing Market Size by Application (2015-2020)

    8 China

    • 8.1 China Oncology Blood Testing Market Size (2015-2020)
    • 8.2 Oncology Blood Testing Key Players in China (2019-2020)
    • 8.3 China Oncology Blood Testing Market Size by Type (2015-2020)
    • 8.4 China Oncology Blood Testing Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Oncology Blood Testing Market Size (2015-2020)
    • 9.2 Oncology Blood Testing Key Players in Japan (2019-2020)
    • 9.3 Japan Oncology Blood Testing Market Size by Type (2015-2020)
    • 9.4 Japan Oncology Blood Testing Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Oncology Blood Testing Market Size (2015-2020)
    • 10.2 Oncology Blood Testing Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Oncology Blood Testing Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Oncology Blood Testing Market Size by Application (2015-2020)

    11 India

    • 11.1 India Oncology Blood Testing Market Size (2015-2020)
    • 11.2 Oncology Blood Testing Key Players in India (2019-2020)
    • 11.3 India Oncology Blood Testing Market Size by Type (2015-2020)
    • 11.4 India Oncology Blood Testing Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Oncology Blood Testing Market Size (2015-2020)
    • 12.2 Oncology Blood Testing Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Oncology Blood Testing Market Size by Type (2015-2020)
    • 12.4 Central & South America Oncology Blood Testing Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 Guardant Health
      • 13.1.1 Guardant Health Company Details
      • 13.1.2 Guardant Health Business Overview and Its Total Revenue
      • 13.1.3 Guardant Health Oncology Blood Testing Introduction
      • 13.1.4 Guardant Health Revenue in Oncology Blood Testing Business (2015-2020))
      • 13.1.5 Guardant Health Recent Development
    • 13.2 Trovagene
      • 13.2.1 Trovagene Company Details
      • 13.2.2 Trovagene Business Overview and Its Total Revenue
      • 13.2.3 Trovagene Oncology Blood Testing Introduction
      • 13.2.4 Trovagene Revenue in Oncology Blood Testing Business (2015-2020)
      • 13.2.5 Trovagene Recent Development
    • 13.3 Genomic Health
      • 13.3.1 Genomic Health Company Details
      • 13.3.2 Genomic Health Business Overview and Its Total Revenue
      • 13.3.3 Genomic Health Oncology Blood Testing Introduction
      • 13.3.4 Genomic Health Revenue in Oncology Blood Testing Business (2015-2020)
      • 13.3.5 Genomic Health Recent Development
    • 13.4 Roche
      • 13.4.1 Roche Company Details
      • 13.4.2 Roche Business Overview and Its Total Revenue
      • 13.4.3 Roche Oncology Blood Testing Introduction
      • 13.4.4 Roche Revenue in Oncology Blood Testing Business (2015-2020)
      • 13.4.5 Roche Recent Development
    • 13.5 Bio-Techne
      • 13.5.1 Bio-Techne Company Details
      • 13.5.2 Bio-Techne Business Overview and Its Total Revenue
      • 13.5.3 Bio-Techne Oncology Blood Testing Introduction
      • 13.5.4 Bio-Techne Revenue in Oncology Blood Testing Business (2015-2020)
      • 13.5.5 Bio-Techne Recent Development
    • 13.6 Pathway Genomics
      • 13.6.1 Pathway Genomics Company Details
      • 13.6.2 Pathway Genomics Business Overview and Its Total Revenue
      • 13.6.3 Pathway Genomics Oncology Blood Testing Introduction
      • 13.6.4 Pathway Genomics Revenue in Oncology Blood Testing Business (2015-2020)
      • 13.6.5 Pathway Genomics Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Oncology Blood Testing. Industry analysis & Market Report on Oncology Blood Testing is a syndicated market report, published as Global Oncology Blood Testing Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Oncology Blood Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,500.00
      $7,000.00
      2,789.50
      5,579.00
      3,265.50
      6,531.00
      546,910.00
      1,093,820.00
      292,145.00
      584,290.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report